Login
Subscribe
Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold
Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold
The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.
The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.
drug development, biotech, disease & medicine
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019 | 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.